Is Restrictive Eating Behavior in Anorexia Nervosa Short-sighted? An Experimental Investigation (EFT in AN)

November 11, 2026 updated by: Caitlin Lloyd, New York State Psychiatric Institute

The investigators will examine the behavioral effects of an experimental Episodic Future Thinking manipulation on food choice, as well as the ability to engage the neural circuits supporting Episodic Future Thinking during food choice, among individuals with anorexia nervosa (AN) and healthy controls.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • New York, New York, United States, 10032
        • New York State Psychiatric Institute
        • Contact:
        • Principal Investigator:
          • Caitlin Lloyd, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 34 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria

Individuals with Anorexia Nervosa:

  1. DSM-5 diagnosis of AN
  2. Right-handed
  3. Hospitalized as an inpatient at New York State Psychiatric Institute
  4. Able to provide informed consent

Healthy controls:

  1. Right-handed
  2. BMI ≥ 18.5 and ≤ 25 kg/m2
  3. No history of eating disorder or other psychiatric illness
  4. Not currently dieting
  5. Able to provide informed consent

Exclusion Criteria

Individuals with Anorexia Nervosa:

  1. Current or lifetime history of DSM-5 schizophrenia, bipolar disorder, or other psychotic-spectrum disorder
  2. High risk of suicide
  3. Food allergy that would interfere with study participation
  4. Daily psychotropic medications within 1 month of the study
  5. Major neurological problem that might affect interpretation of findings
  6. Indwelling metallic object (e.g. braces, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo)
  7. Significant claustrophobia
  8. Pregnancy

Healthy controls:

  1. Any current or lifetime eating disorder
  2. Any current psychiatric disorder
  3. Current psychotropic medication
  4. Food allergy that would interfere with study participation
  5. Major medical or neurological problem that might affect interpretation of findings
  6. Indwelling metallic object (e.g. braces, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo)
  7. Significant claustrophobia
  8. Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Episodic Future Thinking then Standardized Episodic Thinking

This arm involves two experimental manipulations. Participants will complete a task with the episodic future thinking manipulation; after they will complete the same task with the standardized future thinking manipulation.

Participants will be presented with individualized cues to prompt thinking about future scenarios.

Participants will be presented with individualized cues to prompt thinking about recent (standardized) study-related events.

Experimental: Standardized Episodic Thinking

This arm involves two experimental manipulations. Participants will complete a task with the standardized future thinking; after they will complete the same task with the episodic future thinking manipulation manipulation.

Participants will be presented with individualized cues to prompt thinking about future scenarios.

Participants will be presented with individualized cues to prompt thinking about recent (standardized) study-related events.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High-fat preference
Time Frame: Day 1

Participants complete a computerized food decision making task in which they indicate their preference to eat different food items.

Day 1
Reward discount rate
Time Frame: Day 1

On a computer task participant selects between smaller monetary rewards available sooner and larger delayed monetary rewards, allowing the discounting of delayed rewards to be calculated.

Day 1
Functional connectivity between ventromedial prefrontal cortex and hippocampus
Time Frame: Day 1

Brain activation during study tasks will be assessed with functional magnetic resonance imaging, and functional connectivity between ventromedial prefrontal cortex and hippocampus will be estimated.

Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

April 15, 2028

Study Completion (Estimated)

April 15, 2028

Study Registration Dates

First Submitted

November 7, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NYSPI2025-88
  • R21MH141583 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

This study will offer participants the opportunity to share data with the National Data Archive. This is not a requirement for participation.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.